Congenic rats reveal three independent Copenhagen alleles within the Mcs1 quantitative trait locus that confer resistance to mammary cancer.

It has previously been shown that the Copenhagen (COP) rat contains several genetic loci that contribute to its mammary tumor-resistant phenotype after 7,12-dimethylbenz(a)anthracene (DMBA) administration. One of these loci, mammary carcinoma susceptibility 1 (Mcs1), is located on the centromeric end of chromosome 2 and appears to act in a semidominant fashion. To confirm the existence and independent action of this locus and also aid in the identification of the physical location of the Mcs1 gene, congenic lines were generated by transferring the Mcs1 COP allele onto a Wistar Furth (WF) genetic background. Male carriers were genotyped using microsatellite markers spanning 20-30 cM of the Mcs1 locus. One of the congenic lines minimally retained the COP allele at D2Mit29 on the centromeric end of chromosome 2 and extended distally to D2Rat201. Heterozygous Mcs1 carrier rats were interbred, and the female offspring were treated with DMBA. The female rats from the Mcs1 congenic line that carried one or two COP alleles of the Mcs1 region had a significantly reduced (65 and 85%, respectively) tumor development (P < 0.001) compared with rats carrying zero COP alleles at this locus. A WF.COP-D2Mit29/D2Rat201 homozygous congenic strain derived at the N10 generation was treated with DMBA, and the COP homozygous rats developed 1.5 +/- 0.3 carcinomas/rat versus 6.3 +/- 0.5 in WF control rats (P < 0.0001). Fine mapping of this congenic interval using several recombinant lines identified three genetic loci within the Mcs1 congenic region that independently supported a tumor resistance phenotype. These genetic loci have been termed Mcs1a, Mcs1b, and Mcs1c. In rats for which each locus was homozygous for the COP allele, tumor development was reduced by approximately 60% compared with littermate controls. The identification of these independent loci within the Mcs1 COP allele provide a model of the genetic complexity of cancer.

[1]  M. Gould,et al.  Modulation of Mammary Carcinogenesis by Echancer and Suppressor Genes , 2020 .

[2]  I. Costa,et al.  Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumors. , 2002, Archives of pathology & laboratory medicine.

[3]  E. D. de Vries,et al.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility , 2002, Journal of medical genetics.

[4]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[5]  B. Weber,et al.  "Other" breast cancer susceptibility genes: searching for more holy grail. , 2001, Human molecular genetics.

[6]  N. Spector.  Cancer, genes, and the environment. , 2000, The New England journal of medicine.

[7]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[8]  M A Newton,et al.  Genetic identification of multiple loci that control breast cancer susceptibility in the rat. , 1998, Genetics.

[9]  J. Shull,et al.  Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas. , 1998, Cancer letters.

[10]  T. Tsukamoto,et al.  Synergistic effect of MNU and DMBA in mammary carcinogenesis and H-ras activation in female Sprague-Dawley rats. , 1997, Cancer letters.

[11]  Norifumi Ueda,et al.  Incidence of p53 and Ha‐ras gene mutations in chemically induced rat mammary carcinomas , 1996, Molecular carcinogenesis.

[12]  E. Lander,et al.  Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. , 1994, Cancer research.

[13]  S. Morii,et al.  Strain difference in neoplastic response to DMBA powder dusted onto mammary tissues between Wistar/Furth and Copenhagen strains of rats. , 1990, The Japanese journal of experimental medicine.

[14]  M. Gould,et al.  Comparison of 7,12-dimethylbenz[a]anthracene metabolism and DNA binding in mammary epithelial cells from three rat strains with differing susceptibilities to mammary carcinogenesis. , 1988, Carcinogenesis.

[15]  J. Isaacs.  Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. , 1986, Cancer research.

[16]  M. Barbacid,et al.  Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations , 1983, Nature.

[17]  M. R. Curtis,et al.  The incidence of diethylstilbestrol-induced cancer in reciprocal F hybrids obtained from crosses between rats of inbred lines that are susceptible and resistant to the induction of mammary cancer by this agent. , 1952, Cancer research.

[18]  M. R. Curtis,et al.  Strain differences in response to diethylstilbestrol and the induction of mammary gland and bladder cancer in the rat. , 1947 .

[19]  M. Newton,et al.  Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat. , 2001, Genetics.

[20]  R. Burdon.  Genes and the environment , 1999 .

[21]  H. Rabes,et al.  Cell proliferation and prevalence of ras gene mutations in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors , 1993, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.